Fuller & Thaler Asset Management
CSII

Fuller & Thaler Asset Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

Fuller & Thaler Asset Management’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-57
Closed -$2K – 569
2020
Q4 		$2K Sell
57
-231,550
-100% -$8.71M ﹤0.01% 519
2020
Q3 		$9.11M Buy
231,607
+2,502
+1% +$80.8K 0.12% 175
2020
Q2 		$7.23M Buy
+229,105
New +$8.56M 0.09% 199
2018
Q4 		– Sell
-223,966
Closed -$8.77M – 492
2018
Q3 		$8.77M Buy
+223,966
New +$8.28M 0.09% 170

Other funds holding CSII

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Fuller & Thaler Asset Management's CSII Position: Q1 2021 in Review

Fuller & Thaler Asset Management sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2021, closing a stake of 57 shares — an estimated $2K sold.

Fuller & Thaler Asset Management first reported a position in CSII in Q3 2018 and held it in 4 quarters. The position peaked at $9.11M in Q3 2020. 174 funds tracked by Wall St. Rank hold CSII as of Q1 2021.

  • Fuller & Thaler Asset Management reported no remaining Cardiovascular Systems, Inc. position as of Q1 2021 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 57 Cardiovascular Systems, Inc. shares in Q1 2021, an estimated $2K.
  • Fuller & Thaler Asset Management first reported a position in Cardiovascular Systems, Inc. in Q3 2018 and held it in 4 quarters.
  • Fuller & Thaler Asset Management's Cardiovascular Systems, Inc. position peaked at $9.11M in Q3 2020.
  • 174 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2021.

Based on Fuller & Thaler Asset Management's 13F filing for Q1 2021, filed 13 May 2021.